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ABSTRACT
DAZ-associated protein 1 (DAZAP1) is an RNA-binding protein required for normal growth, development, and fertility in mice.
However, its molecular functions have not been elucidated. Here we find that Xenopus laevis and human DAZAP1, which are
each expressed as short and long forms, act as mRNA-specific activators of translation in a manner that is sensitive to the
number of binding sites present within the 39 UTR. Domain mapping suggests that this conserved function is mainly associated
with C-terminal regions of DAZAP1. Interestingly, we find that the expression of xDAZAP1 and its polysome association are
developmentally controlled, the latter suggesting that the translational activator function of DAZAP1 is regulated. However,
ERK phosphorylation of DAZAP1, which can alter protein interactions with its C terminus, does not play a role in regulating its
ability to participate in translational complexes. Since relatively few mRNA-specific activators have been identified, we
explored the mechanism by which DAZAP1 activates translation. By utilizing reporter mRNAs with internal ribosome entry
sites, we establish that DAZAP1 stimulates translation initiation. Importantly, this activity is not dependent on the recognition of
the 59 cap by initiation factors, showing that it functions downstream from this frequently regulated event, but is modulated by
changes in the adenylation status of mRNAs. This suggests a function in the formation of ‘‘end-to-end’’ complexes, which are
important for efficient initiation, which we show to be independent of a direct interaction with the bridging protein eIF4G.
Keywords: mRNA-specific translational control; untranslated regions; proline-rich RNA-binding protein (Prrp); gametogenesis;
multifunctional RNA-binding proteins
INTRODUCTION
The RNA-binding protein Deleted in Azoospermia (DAZ)–
associated protein 1 (DAZAP1), also known as proline-
rich RNA-binding protein (Prrp), contains two RNA-
recognition motifs (RRMs) and is a member of the family of
heterogeneous RNA-binding proteins (Akindahunsi et al.
2005). While most Dazap1-deficient (and -hypomorphic)
mice die perinatally due to growth defects, the few surviv-
ing Dazap1-hypomorphic male progeny contain no post-
pachytene spermatocytes, indicating roles for Dazap1 in nor-
mal growth, development, and spermatogenesis (Hsu et al.
2008). Surviving Dazap1-hypomorphic female mice are
also sterile (Hsu et al. 2008). However, the molecular func-
tions of Dazap1 and their relative contributions to these
phenotypes remain unclear, although its ability to bind RNA
(Tsui et al. 2000a; Zhao et al. 2001) suggests that Dazap1 is
likely to have a role in regulating post-transcriptional gene
expression.
Mammalian DAZAP1 is widely expressed in adults with
high levels of expression in testis (Tsui et al. 2000a,b; Dai et al.
2001; Kurihara et al. 2004; Hori et al. 2005; Pan et al. 2005).
Within the pachytene spermatocytes and round spermatids
of the mouse testis, Dazap1 is predominantly nuclear
(Kurihara et al. 2004) and may have nuclear functions as it
can play a minor role in mini-gene splicing in human cell
lines (Goina et al. 2008; Skoko et al. 2008).
In elongating spermatids in mouse (Kurihara et al. 2004)
and during oogenesis in Xenopus laevis (Zhao et al. 2001),
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DAZAP1 is cytoplasmic, suggesting it may also have gene
regulatory roles in the cytoplasm. In support of this, DAZAP1
interacts with the actin-associated protein profilin (Zhao et al.
2001) and forms part of a large protein complex bound to the
39 UTR of mRNAs, such as Vg1 and VegT, that are localized
within X. laevis oocytes (Zhao et al. 2001). This suggests a
potential role inmRNA localization consistent with the ability
of human DAZAP1 (hDAZAP1) to shuttle between the nu-
cleus and the cytoplasm (Vera et al. 2002; Lin and Yen 2006).
However, a role in mRNA transport/localization/anchoring
remains to be firmly established.
A potential role in mRNA translation was initially sug-
gested by the association of hDAZAP1 with the DAZ family
of proteins (Tsui et al. 2000a). This family (DAZ, DAZ-like
[DAZL], and BOULE) activates the translation of specific
mRNAs inmetazoan germ cells (Maegawa et al. 2002; Collier
et al. 2005; Reynolds et al. 2005, 2007; Brook et al. 2009) via
an interaction with the translation factor poly(A)-binding
protein (PABP) (Collier et al. 2005). DAZAP1 interacts with
the DAZmotif (Maegawa et al. 2002), which is required both
for the polysomal association of members of this family and
for their ability to fully stimulate translation of reporter
mRNAs (Tsui et al. 2000b; Maegawa et al. 2002; Collier et al.
2005). Thus, DAZAP1 could contribute to DAZ-mediated
translational activation. Alternatively, it may negatively
regulate translation by preventing DAZ binding to proteins,
such as PABP, that are required for its ability to activate
translation. This is consistent with the observation that
human DAZ cannot simultaneously interact in vitro with
human PABP1 and DAZAP1 (Morton et al. 2006) and with
the absence of Dazap1 on the polysomes in the testis of adult
mice (Dai et al. 2001). Thus, although no role in translation
has been established for DAZAP1, these studies raise the
possibility that DAZAP1 may repress or activate translation
and/or modulate the activity of the DAZ family. Since
DAZAP1 is expressed in a much wider range of cell types
than DAZ family members (Tsui et al. 2000a,b; Dai et al.
2001; Kurihara et al. 2004; Hori et al. 2005; Pan et al. 2005;
Brook et al. 2009), DAZAP1 may also regulate translation
independently of DAZ proteins, consistent with the ability of
many RNA-binding proteins to participate in multiple
regulatory complexes. In keeping with this idea, X. laevis
DAZL (Xdazl) has not been reported to bind Vg1 and VegT
mRNAs, suggesting that the roles of DAZAP1 and the DAZ
family may be separable even when present in the same cell
type.
Here we investigate the attractive hypothesis thatDAZAP1
functions as a translational regulator and find that X. laevis
DAZAP1 can activate translation in anmRNA-specific man-
ner. This activity requires the C terminus of the protein and
appears to be regulated during X. laevis development, in an
ERK-independent manner. In exploring the mechanism
of DAZAP1-mediated activation, we find that it stimulates
an early step in initiation, downstream from the initial cap-
binding event, and present a model in which it regulates
end-to-end complex formation independently of a direct
interaction with eukaryotic initiation factor (eIF)4G. Similar
results were obtained with hDAZAP1 suggesting that this
represents an evolutionarily conserved function of DAZAP1
proteins, which may contribute to their critical roles in de-
velopment and gametogenesis.
RESULTS
X. laevis DAZAP1 stimulates the translation
of reporter mRNAs
The interacting protein partners of DAZAP1 suggest poten-
tial roles in regulating mRNA utilization in the cytoplasm,
including translational control. Tethered-function analysis
enables the assessment of a potential role of DAZAP1 in
mRNA translation in intact cells without knowledge of its
endogenous target mRNAs (Coller et al. 1998; Gray et al.
2000). A luciferase reporter mRNA (luc-MS2) containing 39
UTR binding sites for the phage MS2 coat protein, a small
RNA-binding protein, was co-injected with an internal
control mRNA into X. laevis oocytes expressing DAZAP1
or control proteins fused to MS2 (Fig. 1). The interaction of
MS2 with its cognate RNA-binding sites on the mRNA
‘‘tethers’’ DAZAP1 to the reporter mRNA (Gray et al. 2000),
and effects on translation are determined by luciferase assay.
Since reporter mRNAs are directly injected into the cyto-
plasm, any effects on transcription, splicing, or export are
negated. Interestingly, luciferase expression (normalized for
the activity of the b-galactosidase internal control mRNA)
was significantly enhanced (5.5-fold) (Fig. 1A) in oocytes
expressing MS2-xDAZAP1 compared with MS2-U1A (Fig.
1A,B). U1A is an RNA-binding protein involved in mRNA
splicing (Jovine et al. 1996) rather than translation and acts as
a negative control (Gray et al. 2000). Reporter mRNA levels
immediately after injection and at the end of the assay period
were compared by quantitative RT-PCR analysis. No sig-
nificant changes were detected, either between oocytes ex-
pressingMS2-U1AorMS2-xDAZAP1 or over time (Fig. 1C).
This confirms that xDAZAP1 does not affect mRNA stability
but rather activates mRNA translation, consistent with the
absence ofmRNA turnover in stage VI oocytes. Interestingly,
the effect of xDAZAP1 is mRNA specific since neither the
translation of the control b-galactosidase (data not shown)
nor a luciferase reporter mRNA lacking MS2-binding sites
(luc-DMS2) was stimulated by MS2-xDAZAP1 (Fig. 1D).
Similarly, stimulation required that xDAZAP1 be fused to
theMS2 protein, since expression of xDAZAP1 alone did not
stimulate reporter mRNA translation (Fig. 1E); tethered
PABP1 (Gray et al. 2000) served as a positive control (Fig.
1E). In conclusion, xDAZAP1 activates the translation of
mRNAs only when bound, indicative of a role as an mRNA-
specific activator, adding to the handful of such regulatory
proteins identified (Vende et al. 2000; Gorgoni et al. 2005;
Cakmakci et al. 2008; Michlewski et al. 2008).
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DAZAP1 expression during X. laevis embryogenesis
Our findings suggest that the requirement for Dazap1 for
normal developmentmay be due, at least in part, to its ability
to stimulate translation of specific mRNAs during develop-
ment; however, little is known about its developmental
expression pattern in any species (Dai et al. 2001). To address
this, polyclonal antibodies were raised against xDAZAP1,
which is described as a 360-amino-acid protein (Zhao et al.
2001). Our antibodies recognized recombinant xDAZAP1
(data not shown) and closely migrating bands in fully grown
stage VI oocytes, in vitro matured oocytes, or unfertilized
eggs (Fig. 2A,B). Post-fertilization, xDAZAP1 persisted
throughout the early cleavages (Fig. 2B). Zygotic transcrip-
tion ensues at mid blastula transition (stage 8) and is ac-
companied by a destruction of maternal mRNAs. Following
gastrulation, a small increase in xDAZAP1 levels, expressed
from zygotically derived mRNA, is observed by the neural
plate stage (stage 14), suggesting a requirement for xDAZAP1
protein (Fig. 2B). Levels continue to rise gradually and more
markedly from stage 28 until 33/34, with a significant in-
crease at stage 35/36 when the embryos hatch. High levels
of xDAZAP1 are maintained until stage 41 (Fig. 2B), during
which time external morphological changes, such as tail
elongation, continue and organogenesis progresses (for fur-
ther information on X. laevis embryogenesis, see legend to
Fig. 2B).
In many developmental stages, xDAZAP1 appeared to be
present in multiple forms. This is consistent with a previous
study of oogenesis using a different antibody (Zhao et al.
2001). In this study, the faster migrating form ran equiva-
lently to Escherichia coli expressed xDAZAP1, suggesting
the possibility of post-translational modification. Since
hDAZAP1 is phosphorylated by ERK1/2, the phosphoryla-
tion status of xDAZAP1 was investigated in stage VI oocytes
and progesterone matured oocytes, as many kinase path-
ways, including ERK2 (ERK1 is not conserved in X. laevis),
are activated uponmaturation. However, phosphatase treat-
ment of extracts from stage VI or mature oocytes did not
resolve both forms into a single species, although ERK was
efficiently dephosphorylated (Fig. 2C). This does not exclude
the possibility that xDAZAP1 is a phosphoprotein, but sug-
gests that the observed forms represent either phosphoryla-
tions that are refractory to alkaline phosphatase treatment,
alternative post-translational modifications, or splice vari-
ants. Interestingly, splice variants of hDAZAP1 are annotated
with an alternative 39 exon that encodes a 378-amino-acid
protein, rather than the previously characterized 407-amino-
acid protein. To determine whether alternative splicing may
account for the multiple forms observed in X. laevis, bio-
informatic searches were undertaken using the C-terminal
exon of the 407-amino-acid form of hDAZAP1. This iden-
tified X. laevis cDNA sequences that encode a 405-amino-acid
xDAZAP1 protein, with the alternative C terminus showing
75% identity with the 407-amino-acid human protein
(Fig. 2D). mRNAs corresponding to both splice forms were
detectable by RT-PCR analysis of total RNA in stage VI
oocytes (data not shown), and similar splice variants are
conserved in Xenopus tropicalis. The difference in predicted
FIGURE 1. (Legend on next page)
Smith et al.
1284 RNA, Vol. 17, No. 7
molecular weight between the two splice forms is 4 kDa,
consistent with the migration of the observed protein bands.
Thus both mammalian and X. laevis DAZAP1 appear to be
expressed as multiple splice variants that vary in their
extreme C termini.
xDAZAP1 is present in polysomal fractions
Having established that tethered xDAZAP1 has the capacity
to stimulate translation of reporter mRNAs, we tested
whether endogenous xDAZAP1 also fulfils this role by
investigating its ribosomal association at different develop-
mental stages. To this end, the association of xDAZAP1 with
actively translating ribosomes (polysomes) was examined by
sucrose gradient analysis of extracts followed by Western
blotting of the resulting fractions. Analysis of extracts from
stage VI oocytes revealed that xDAZAP1 was essentially re-
stricted to the monosome/diasome fractions of the gradient
(Fig. 3A), which contain free 80S ribosomes and mRNAs
bound by one or two ribosomes (Gray 1998). This is in con-
trast to ePABP, a member of PABP family of proteins, that
sedimented with both messenger ribonucleoprotein com-
plexes (mRNPs) and polysomes (Fig. 3A, lower panel;Wilkie
et al. 2005). This suggests that xDAZAP1 is not associated
with efficiently translated mRNAs at this stage, and its
unusual sedimentation may be due to its association with
large complexes that are not ribosomal. In contrast, in stage
40–41 embryos where xDAZAP1 is more highly expressed,
besides being present in fractions containing mRNPs, a sig-
nificant proportion of xDAZAP1 was found in predomi-
nantly lighter polysome fractions (Fig. 3B,C). As expected,
PABP1 sedimented with mRNPs and polysomes. Pretreat-
ment of extracts with EDTA, which dissociates RNA–protein
complexes including polysomes, caused both xDAZAP1 and
PABP1 to largely redistribute to lighter fractions (Fig. 3B),
consistent with the association of a proportion of xDAZAP1
with actively translating mRNAs. To confirm its polysome
association, extracts were treated with puromycin, which acts
as a peptide chain terminator by mimicking the 39 end of
aminoacyl-tRNA and specifically promotes the release of
mRNAs from ribosomes. Importantly, puromycin treatment
results in the redistribution of the majority of xDAZAP1 and
PABP1 to the mRNP fractions (Fig. 3C), establishing that the
sedimentation of xDAZAP1 into the heavier fractions is due to
its association with endogenous mRNAs on actively trans-
lating polysomes. Longer exposures showed that the different
forms of xDAZAP1 were represented on polysomes (Fig. 3C).
Taken together with the results of our reporter assays, these
data strongly support a role for xDAZAP1 in the translational
activation of specific endogenous mRNAs.
Translational activation by DAZAP1 is conserved
Our findings with respect to xDAZAP1 differ from the
proposed roles for mammalian DAZAP1 (Dai et al. 2001;
Morton et al. 2006), although the long and short protein
forms are 82% and 83% identical, respectively. However, the
role of mammalian DAZAP1 in translation has never been
directly tested. To address this, an MS2-hDAZAP1 fusion,
containing the previously studied 407-amino-acid (long)
form (Morton et al. 2006; Yang et al. 2009), was expressed in
stage VI X. laevis oocytes (Fig. 4A). Consistent with their
predicted molecular weights, MS2-hDAZAP1 showed re-
duced mobility in SDS-PAGE compared with the 360-
amino-acid form of xDAZAP1 in oocytes (cf. Figs. 4A and
1B) or when expressed in vitro (Fig. 4B). Interestingly,
injection of the tethered-function reporter mRNAs into
oocytes expressing MS2-U1A, MS2-hDAZAP1, or MS2-
DAZL as a positive control for translational activation
(Collier et al. 2005) revealed that hDAZAP1 was also capable
of stimulating translation (Fig. 4C), as mRNA stability was
not altered (data not shown). The level of activation by
hDAZAP1 was quantitatively similar to that of xDAZAP1
(Fig. 1A), and the effects of hDAZAP1 were also mRNA
specific (Fig. 4D), suggesting that this function is an evolu-
tionarily conserved property of both short and long forms
of DAZAP1.
ERK phosphorylation does not regulate
the translational activity of DAZAP1
ERK1/2 phosphorylation on threonine 269 and 315 (Fig. 2D)
can affect the protein interactions mediated by hDAZAP1
in vitro (Morton et al. 2006). These threonine residues are
conserved, albeit in an altered context in xDAZAP1 (Fig. 2D),
and our polysome analysis (Fig. 3A) supports the possibility
that xDAZAP1 has roles in addition to translational control,
consistent with the idea that ERK may regulate its participa-
tion in translation complexes. Thus we examined the relative
ability of xDAZAP1 to stimulate translation in both stage VI
and mature oocytes, since ERK2 is activated in the latter
(Fig. 2C). In contrast to some other characterized regulators
(e.g., Gorgoni et al. 2005; Wilkie et al. 2005), the ability of
DAZAP1 to stimulate translation was not significantly
FIGURE 1. X. laevis DAZAP1 can stimulate translation. (A) Oocytes
expressing MS2-xDAZAP1 or MS2-U1A were co-injected with luc-
MS2 reporter and b-galactosidase control mRNAs. Luciferase values
were corrected for any minor changes in the levels of b-galactosidase
and plotted as relative stimulation compared with the control fusion
protein MS2-U1A, which is set to 1. (B) SDS-PAGE analysis of
35
S-
Met–labeled uninjected () oocytes or those injected with MS2-U1A
or MS2-xDAZAP1 mRNAs. MS2-U1A and MS2-xDAZAP1 contain
21 and 13 methionine residues, respectively. The position of fusion
proteins are indicated by asterisks. (C) mRNA was isolated from the
oocytes in A either immediately after injection (t = 0) or after 16 h
(t = 16), and mRNA levels were determined by qRT-PCR. Mean Ct
values are shown. (D) Oocytes expressing MS2-U1A or MS2-xDA-
ZAP1 were injected with b-galactosidase and luciferase mRNAs with
(luc-MS2) or without (luc-DMS2) MS2-binding sites. (E) luc-MS2
and b-galactosidase mRNAs were injected into oocytes expressing
MS2-U1A, DMS2-xDAZAP1, or MS2-PABP1, which serves as a pos-
itive control. Data in D and E are plotted as described in A.
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affected bymaturation (Fig. 5A), suggesting that thisDAZAP1
activity is not regulated by signaling pathways that are ac-
tivated upon maturation. However, it is not known whether
xDAZAP1 is an in vivo substrate of ERK2 during matura-
tion or whether such phosphorylation is highly transient.
Therefore to examine the role of ERK directly, we introduced
point mutations that act as phosphomutants (AA) or phos-
phomimetics (DD) of threonine 269 and 315 in hDAZAP1.
Neither manipulation significantly altered hDAZAP1 activity
in either stage VI (data not shown) or mature oocytes (Fig.
5B), showing that phosphorylation at these residues does not
regulate protein interactions that are required for the trans-
lational stimulatory activity of DAZAP1.
Multiple binding sites enhance the level
of activation by DAZAP1
Many 39 UTR-binding proteins bind to elements that are
present in multiple copies within the 39 UTR, with multiple
elements having an additive effect on translational regulation
(e.g., Ostareck-Lederer et al. 1994; Collier et al. 2005), al-
though others only benefit from a single binding site
(Sanchez and Marzluff 2002; Gorgoni et al. 2005). To
investigate whether activation by DAZAP1 is sensitive to
the number of molecules that can bind to the 39 UTR,
reporter mRNAs with different numbers of MS2-binding
sites were tested (Fig. 6). xDAZAP1 weakly stimulated the
translation of an mRNA with one binding site (Fig. 6), with
the magnitude of stimulation markedly increasing in the
presence of three binding sites (Fig. 6). However the trans-
lation of a reportermRNA containing nine, rather than three,
binding sites was not further enhanced (Fig. 6). hDAZAP1
showed similar functional characteristics (Supplemental Fig.
S1). This suggests that the physiological target mRNAs that
are translationally regulated by DAZAP1, including those
that may be required for normal development, may contain
multiple DAZAP1-binding sites.
DAZAP1 enhances translation initiation
To begin to address the mechanism by which DAZAP1
activates translation, we sought to determine whether it acts
during initiation or later, during elongation or termination.
To this end, we utilized a nonphysiologically capped reporter
mRNA containing a classical swine fever virus (CSFV)
internal ribosome entry site (IRES) within its 59 UTR (Fig.
FIGURE 2. Developmental expression pattern and alternative splicing of X. laevis DAZAP1. Western blots of extracts probed with antibodies
against xDAZAP1 or tubulin (control), prepared from (A) fully grown oocytes (stage VI), in vitro matured (mature), or unfertilized eggs (egg); or
(B) unfertilized eggs or embryos (up to stage 41) according to the tables of Nieuwkoop and Faber (1994). After the 12 initial cleavages following
fertilization, zygotic transcription ensues at the mid blastula transition (stage 8) with gastrulation being initiated at stage 10. The neural plate (stage
14) starts to fold at stage 15, with the neural tube being completely closed by stage 21. The tail bud is discernable at stage 24, at which time embryos
exhibit response to external stimuli with spontaneous movement beginning at stage 26. By stage 28, the general pattern of the brain is largely
established, and by stage 29/30, the tail bud is distinct with 24–25 somites segregated, with segregation reaching the tail. The heart starts beating at
stage 33/34 with hatching initiating at stage 35/36, when the length of the tail bud is about three times its breadth. The entire pronephros is functional
by stage 37/38, with the mouth breaking through at stage 40 and initial torsion of the intestine and segregation of the primordial germ cells occurring
at stage 41. (C) Extracts from stage VI and progesterone matured oocytes were untreated () or treated with calf intestinal phosphotase (CIP; +) and
analyzed by Western blot using the indicated antibodies. ERK2 is active when phosphorylated (P-ERK). (D) Comparison of the C-terminal region
of the long forms of xDAZAP1 and hDAZAP1, with identities shown in black and similarities shown in gray. The newly identified alternative
C-terminal exon of xDAZAP1 is underlined, and ERK-phosphorylated threonine residues in hDAZAP1 are indicated by asterisks.
Smith et al.
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7A; Supplemental Fig. S2A). Translation is initiated at IRESs
via an alternative pathway through which 40S ribosomal
subunits are directly recruited to a site within the 59 UTR
independently of the 59 cap (Jackson 2005; Doudna and
Sarnow 2007). Although the CSFV IRES directs efficient
translation in oocytes (Gorgoni et al. 2005), neither
xDAZAP1 (Fig. 7A) nor hDAZAP1 (Supplemental Fig.
S2A) was able to stimulate translation driven by this IRES,
although they activated cap-dependent translation (Fig. 7A;
Supplemental Fig. S2A). Since elongation and termination,
but not initiation, progress normally in CSFV IRES-medi-
ated translation (Pestova et al. 1998, 2008), this reveals that
DAZAP1 acts during the initiation phase of translation.
Initiation has several mRNA-dependent steps (Pestova et al.
2007). The cap is bound by the eIF4F complex,which consists
of the cap-binding factor eIF4E, the scaffold protein eIF4G,
and eIF4A, an RNA helicase whose activity in removing
secondary structure within the 59 UTR is stimulated by
eIF4B. Subsequent binding of the small ribosomal subunit
and associated factors (eIF2-GTP-Met, eIF3, eIF1, eIF1A,
eIF5) is aided by eIF4G–eIF3 interactions. This complex then
scans the 59 UTR for an initiation codon, and upon its
recognition, initiation factors are released and the large
ribosomal subunit joins. As CSFV only deviates from the
cap-dependent pathway during the earlier steps of initiation
(Pestova et al. 1998, 2008), this suggests that DAZAP1 acts
prior to large ribosomal subunit recruitment.
DAZAP1 can stimulate translation independently
of the cap
IRESs differ significantly in their mechanism of ribosomal
subunit recruitment and initiation factor requirements,
making them a useful tool with which to dissect initiation
mechanisms (Jackson 2005; Doudna and Sarnow 2007). The
inability of DAZAP1 to stimulate initiation from a CSFV
IRES led us to question whether DAZAP1 activity is strictly
cap-dependent and, therefore, incapable of stimulating cap-
independent translation in general. To address this, we ex-
amined the ability of DAZAP1 to stimulate mRNAs that
FIGURE 3. Polysomal association of X. laevis DAZAP1. Stage VI X. laevis oocytes (A) or stage 40–41 embryos (B,C) were subjected to sucrose
gradient analysis, and the resulting UV absorbance profiles (254 nm) of cycloheximide-(Cyclo, thin line) or EDTA-treated (thick line) extracts are
shown. In stage VI oocytes, polysome peaks are not observed, as only 2% of ribosomes are actively engaged in translation, with the majority of
ribosome subunits associating as empty 80S couples. By stage 41, polysome peaks can be clearly discerned. The resulting fractions were probed by
Western blot for xDAZAP1 and either ePABP (A) or PABP1 (B,C), depending on developmental stage. EDTA (B) and puromycin (puro; C)
treatment both cause the majority of xDAZAP1 and PABP1 to be released from polysomes. In B, five times more protein was loaded into fractions
5–10 to allow enhanced visualization of the association of DAZAP1 and PABP1 with polysomes. The longer exposure of polysomal fractions in C
shows that both forms of xDAZAP1 associate with polysomes. The positions of polysomes, the 80S monosome, and mRNP fractions are indicated.
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contain an alternative IRES or possess an ApppG cap and are
translated in a non-IRES–mediated cap-independent man-
ner (Fig. 7B,C; Supplemental Fig. S2B,C). The hepatitis A
virus (HAV) IRES, which can promote cap-independent
initiation in X. laevis oocytes (RWP Smith, O Larralde, B
Gorgoni, P Malik, SV Graham, and NK Gray, in prep.),
differs from the CSFV IRES as it requires all of the canonical
initiation factors, including the cap-binding factor eIF4E,
which is not required by the majority of characterized IRESs
(Jackson 2005). However, eIF4E is not involved in cap
recognition in HAV IRES-mediated initiation but rather
induces a translation-competent conformation in eIF4G
bound to the IRES (Ali et al. 2001; Borman et al. 2001).
The translation of ApppG-capped mRNAs occurs indepen-
dently of eIF4E, which specifically recognizes m7GpppN
(Pestova et al. 2007), and with dramatically reduced effi-
ciency in oocytes (Gillian-Daniel et al. 1998), in which trans-
lation is highly cap-dependent. Injection of the HAV IRES
or cap-independent reporter mRNA into oocytes expressing
either MS2-xDAZAP1 (Fig. 7B,C) or MS2-hDAZAP1 (Sup-
plemental Fig. S2B,C) fusion proteins showed that these
stimulated translation of both reporter mRNAs. The HAV
IRES and cap-independent reporters were stimulated with
somewhat reduced or enhanced efficiency, respectively, com-
pared with the cap-dependent mRNA; the former may be a
result of noncanonical use of eIFs. Thus, DAZAP1-mediated
regulation is not strictly cap-dependent, and our data in-
dicate that DAZAP1 does not act to enhance binding of the
cap by the eIF4F complex, via eIF4E, but acts to enhance
initiation downstream from this event.
DAZAP1-mediated regulation is poly(A)-sensitive
Translation initiation is promoted by the poly(A) tail, which
like the 59 cap is a primary determinant of translational
efficiency (Kahvejian et al. 2005) through its role in forming
so-called end-to-end complexes or closed-loop conforma-
tions, which bring the 59 and 39 UTRs into proximity via an
interaction between PABP, bound to the poly(A) tail, and
eIF4G bound to the 59 UTR as part of the eIF4F complex.
Poly(A) tail length is dynamic and highly regulated during
gametogenesis and development (Richter 1999), and thus,
we sought to determine whether the activity of DAZAP1
could be affected by the adenylation status of target mRNAs
by using adenylated and nonadenylated reporter mRNAs
in tethered-function assays (Fig. 8; Supplemental Fig. S3).
As expected, polyadenylated mRNAs were translated more
FIGURE 4. Human DAZAP1 has a conserved ability to stimulate
translation. SDS-PAGE analysis of (A)
35
S-Met labeled uninjected ()
oocytes or those injected with MS2-U1A or MS2-hDAZAP1 mRNAs
or (B) in vitro translated MS2-xDAZAP1, MS2-hDAZAP1, or control
(). MS2-U1A, MS2-hDAZAP1, and MS2-xDAZAP1 contain 21, 12,
and 13 methionine residues, respectively. The positions of fusion
proteins are indicated by asterisks. (C) Tethered-function analysis in
oocytes expressing MS2-U1A, MS2-hDAZAP1, or MS2-mouse Dazl
(mDazl), an mRNA-specific activator that serves as a positive control.
(D) Oocytes expressing MS2-U1A or MS2-hDAZAP1 were injected with
luciferase mRNAs with (luc-MS2) or without (luc-DMS2) MS2-binding
sites and a b-galactosidase mRNA. Data are plotted as in Figure 1A.
FIGURE 5. ERK phosphorylation does not regulate the translational
stimulatory activity of DAZAP1. Tethered-function assays in stage VI
(A) and mature oocytes (A,B) expressing (A) MS2-xDAZAP1 or (B)
wild-type MS2-hDAZAP1 or MS2-hDAZAP1 containing phosphomu-
tant (AA) or phosphomimetic residues (DD). Reporter and internal
control mRNAs were used, and the data are plotted as in Figure 1A.
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efficiently than their nonadenylated counterparts, but
importantly, polyadenylated mRNAs bound by either
xDAZAP1 or hDAZAP1 were translated most efficiently
(Fig. 8A; Supplemental Fig. S3A). However, the relative
stimulation by either DAZAP1 was reduced by the presence
of a long poly(A) tail (Fig. 8B; Supplemental Fig. S3B),
suggesting that DAZAP1 and the poly(A) tail both con-
tribute to initiation by promoting the formation of end-to-
end complexes.
The domains required for translational stimulation
do not interact directly with eIF4G
To explore the regions of DAZAP1 required to stimulate
initiation, a series of deletion mutants were created that
remove one or both of the RRMs or the C-terminal region
(Fig. 9A). Tethering allows the activation capacity of do-
mains to be assessed independently of their role in RNA
binding, as this function is provided by the MS2-fusion
protein. Deletion of the proline-rich C terminus (MS2-DC)
dramatically reduced stimulation to just 27% of full-length
xDAZAP1 activity (Fig. 9B). The C-terminal region alone
(MS2-D1+2) stimulated translation to 46% of the full-length
level, whereas RRM2 plus the C-terminal region (MS2-D1)
conferred 77% stimulatory activity (Fig. 9B). This suggests
that the translational activation function ofDAZAP1 ismainly
conferred by a region that contains RRM2 and at least part of
the C terminus.
Interestingly, a previous study with GST-DAZAP1 trans-
fected into HEK-293 cells identified a large number of
RNA-binding proteins, including a single translation factor,
eIF4G, as potential partners of DAZAP1 (Yang et al. 2009).
Deletion of RRM1 and part of RRM2 of DAZAP1 greatly
reduced the affinity of eIF4G for DAZAP1 (Yang et al. 2009).
Taken together with our findings that a region containing
RRM2 appears to be important for DAZAP1 activity, this
raises the attractive hypothesis that eIF4G may be a direct
protein partner of DAZAP1. To test this, we undertook
a yeast two-hybrid approach. Neither human nor X. laevis
DAZAP1 interacted with an N-terminal region of eIF4G, nor
did they interact with eIF4G lacking only the extreme N
terminus that contains the PABP1-binding site (Fig. 9C;
Pestova et al. 2007). As expected, eIF4E interacted with both
eIF4G fragments. To confirm the absence of an interaction
between eIF4G and DAZAP1, pull-downs with purified
FIGURE 6. DAZAP1-mediated stimulation is enhanced by the pres-
ence of multiple binding sites within the 39 UTR. Oocytes expressing
MS2-U1A and MS2-xDAZAP1 were co-injected with b-galactosidase
control and luciferase reporter mRNAs containing one (luc-MS21),
three (luc-MS23), or nine (luc-MS29) MS2-binding sites within the 39
UTR. luc-MS23 is referred to as luc-MS2 elsewhere. Data are plotted
as in Figure 1A.
FIGURE 7. DAZAP1 can stimulate translation initiation in a cap-
independent manner. Oocytes expressing MS2-U1A and MS2-xDAZAP1
were co-injected with b-galactosidase control mRNA and either
m7G-capped luc-MS2, CSFV-luc-MS2 (A), HAV-luc-MS2 (B), or
ApG-capped-luc-MS2 (C) mRNA. Data are plotted as in Figure 1A.
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recombinant proteins expressed in E. coli were undertaken
(Fig. 9D). Flag-eIF4G failed to pull down DAZAP1 but
efficiently pulled down PABP1, a known partner protein
(Fig. 9D, lower panel). Thus, a direct interaction between
eIF4G andDAZAP1 does not appear to underlie the ability of
DAZAP1 to stimulate translation when bound to the 39 end
of mRNAs.
DISCUSSION
Our results support a conserved role for both short and long
forms of DAZAP1 in mRNA-specific translational activa-
tion. We find that xDAZAP1 is associated with polysomes
(Fig. 3), and show that it can robustly stimulate the trans-
lation of reportermRNAs (Fig. 1). These observations appear
at odds with the suggestion that the long form of hDAZAP1
represses translation (Morton et al. 2006). However its role
in translation was not previously addressed experimentally,
and we show that mammalian DAZAP1 efficiently activates
translation (Fig. 4). Importantly, we find that DAZAP1 only
stimulates the translation of mRNAs to which it is bound
(Figs. 1, 4), showing that it does not act as a global regulator
of initiation, expanding the relatively small number of
mRNA-specific activators that have been described to date.
In most cases of mRNA-specific regulation, and particu-
larly translational activation, the underlying mechanisms are
not well defined. Our results provide an initial insight into
the mechanism by which DAZAP1 stimulates translation. By
using an mRNA dependent for its translation on the CSFV
IRES, wewere able to show thatDAZAP1 regulates translation
initiation (Fig. 7; Supplemental Fig. S2). As events prior to and
including small ribosomal subunit joining are noncanonical
during CSFV-driven initiation, our results suggest that an
early step in initiation is regulated by DAZAP1. However,
the ability of DAZAP1 to direct HAV IRES-mediated and
FIGURE 8. DAZAP1-mediated stimulation is sensitive to the pres-
ence of the 39 poly(A) tail. Oocytes expressing MS2-U1A and MS2-
xDAZAP1 were co-injected with luc-MS2 (luc-MS2-pA) and luc-
MS2-pA and the b-galactosidase control mRNA. (A) Raw luciferase
values corrected for b-galactosidase. (B) Relative stimulation with
MS2-U1A set to 1.
FIGURE 9. DAZAP1 C-terminal regions stimulate translation in-
dependently of a direct interaction with eIF4G. (A) Cartoon showing
the constructs utilized in B, summarizing their relative ability to
stimulate translation, and the co-isolation of eIF4G with full-length
but not truncated GST-DAZAP1 in Yang et al. (2009). (B) Oocytes
expressing MS2-U1A, MS2-xDAZAP1, MS2-DC (amino acids 1–192),
MS2-D1 (amino acids 106–360), or MS2-D1+2 (amino acids 193–
360) were co-injected with the luc-MS2 reporter and b-galactosidase
control mRNAs. Data are plotted as in Figure 1A. (C, top) Cartoon
showing the eIF4G truncations used and the relative locations of
binding sites for the indicated partner proteins. (Bottom) Yeast two-
hybrid assay using 4GNt or 4GDPABP or MS2 (negative control; indi-
cated by lexA) fused to the LexA-DNA-binding domain and xDAZAP1,
hDAZAP1, eIF4E (positive control), or IRP (iron-responsive protein,
negative control) fused to the GAL4-activation domain. Interactions
were detected by qualitative b-galactosidase filter assays. (D, top) SDS-
PAGE analysis of the indicated purified recombinant proteins visual-
ized with Gelcode Blue. (Bottom) Pull-down of Flag-tagged eIF4G
(FLAG-4G) in the presence of purified His-tagged PABP1 or DAZAP1
analyzed by Western blot using anti-His antibodies.
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cap-independent translation (Fig. 7; Supplemental Fig. S2)
shows that its activity is not strictly dependent on the initial
cap-recognition event. Thus, DAZAP1 appears to function
downstream fromcap binding, distinguishing its activity from
other characterized 39 UTR–bound activators that target this
step (Vende et al. 2000; Gorgoni et al. 2005; Cakmakci et al.
2008; Michlewski et al. 2008).
Although DAZAP1-mediated stimulation does not re-
quire the presence of a poly(A) tail, it is sensitive to its
presence (Fig. 8; Supplemental Fig. S3). DAZAP1 has some
homology with Musashi (Akindahunsi et al. 2005), a protein
that can repress translation but also promotes cytoplasmic
polyadenylation (Charlesworth et al. 2006), raising the
possibility that DAZAP1 may stimulate initiation indirectly
by promoting polyadenylation. However, the reporter assays
were performed in stage VI oocytes prior to the onset of
cytoplasmic polyadenylation, and a required sequence ele-
ment (A2UA3) (Richter 2007) was not present in the reporter
mRNAs, making it highly unlikely that changes in poly(A)
tail length underlie the observed effects.
The activity of the poly(A) tail in promoting initiation is
mediated by PABP, which interacts with eIF4G and other
initiation factors bound to the 59end of mRNAs, forming
end-to-end complexes (Mangus et al. 2003). The decrease in
relative stimulation in the presence of the poly(A) tail
(Fig. 8; Supplemental Fig. S3) raises the possibility that
DAZAP1 may play a role in regulating the formation of such
complexes (Fig. 10). In germ cells, but not in other cells, this
could be mediated by DAZ family proteins since these
interact with both DAZAP1 and PABP1. However, triple
DAZAP1–DAZ–PABP complexes fail to form in vitro, and
the interaction of DAZ family proteins with DAZAP1 or
PABP appears mutually exclusive (Morton et al. 2006).
Moreover, the absence of an effect of mutations that disrupt
the DAZAP1–DAZ interaction (Morton et al. 2006) suggests
that interactions with this family are not required for
DAZAP1 to stimulate translation (Fig. 5). It remains a pos-
sibility that other 39 UTR–binding proteins may mediate an
indirect interaction with PABP (Fig. 10). Alternatively,
DAZAP1 may stabilize PABP-eIF4G–mediated complexes
or participate in alternative end-to-end complexes by form-
ing additional protein–protein contacts between the 59 and
39 UTRs (Fig. 10). Such alternative complexes have been
described in the activation of histone mRNA translation
during oocyte maturation (Cakmakci et al. 2008). This may
be achieved by direct or indirect interactions of DAZAP1
with translation initiation factors bound to the 59 UTR.
Intriguingly, eIF4G was shown to be in complexes with
DAZAP1 (Yang et al. 2009), an association that requires
RRM2, a region that is important for stimulatory activity (Fig.
9). A role of eIF4G is also consistent with our findings that
DAZAP1 can promote cap-dependent, cap-independent,
and IRES-mediated initiation (Fig. 7; Supplemental Fig.
S2), functions that are mediated in part by the ability of
eIF4G to bind RNA (Yanagiya et al. 2009). However, eIF4G
and DAZAP1 do not appear to directly interact (Fig. 9),
indicating that any effect on eIF4G function is indirect.
Interestingly, we find that the expression of DAZAP1 and its
associationwithpolysomes is developmentally controlled (Figs.
2, 3), the latter suggesting that its role in activating translation
may be subject to regulation. However, the use of phosphomi-
metic and phosphomutant forms of hDAZAP1 appears to rule
out a role of phosphorylation of Thr269 or 315 in this process.
The regulated polysome association of xDAZAP1 (Fig. 3) and
our results with tethered hDAZAP1 (Fig. 4) suggest that
analysis at particular stages of spermatogenesis or development
may reveal polysomal association of mammalian Dazap1,
which was not observed in adult mouse testis (Dai et al. 2001).
xDAZAP1 from stage VI oocytes sediments to the mono-
some/diasome region of the gradient (Fig. 3A). This may
reflect an association with mRNAs that are being actively
translated by only a small number of ribosomes, the presence
of stalled ribosomes (Wang et al. 1998), or large protein
complexes that block translation (e.g., Gray and Hentze
1994) and/or direct mRNA localization (Gavis et al. 2007).
There is substantial precedent for multi-functional RNA-
binding proteins that link translational activation and re-
pression, mRNA localization, or stability (Gray andWickens
1998), and our data (Fig. 3) combined with that of Zhao et al.
(2001) support a developmental switch in xDAZAP1 activity
FIGURE 10. A model for DAZAP1-mediated translational activation.
DAZAP1 stimulates initiation by participating in or stabilizing end-
to-end complex formation, which functionally links the 59 and 39 ends
of the mRNA, enhancing small ribosomal subunit recruitment (filled
arrow). Our results show that DAZAP1 can mediate this effect in-
dependently of the initial cap-binding step (denoted by broken line).
DAZAP1 does not utilize Xdazl (denoted by a cross), but other
proteins may mediate contact between DAZAP1 and PABP (factor Y),
stabilizing complexes formed between PABP and eIF4G. Alternatively,
DAZAP1 may contact factors at the 59 end providing additional end-
to-end contacts that help stabilize the closed-loop conformation.
Since CSFV and the HAV IRES differ in their requirement for eIF4G,
eIF4A, eIF4B, eIF1, or eIF1A, one of these 59-bound factors may be
contacted directly or indirectly (via factor Y) by DAZAP1; other eIFs are
omitted for clarity. Direct interactions with eIF4G do not occur
(denoted by a cross). Multiple DAZAP1 molecules are shown to indicate
that target mRNAs benefit from multiple binding sites. Solid and dotted
arrows indicate known and potential interactions, respectively. eIFs are
denoted by their numbers or, with eIF4 factors, their letters: AAAA,
poly(A) tail; Y, hypothetical factor(s); 40S, small ribosomal subunit;
solid circle, 59 cap; and curved box, open reading frame.
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from predominantly associating with localized mRNAs
to promoting translation. Thus we favor a model in which
DAZAP1 participates in multiple gene regulatory events
and may, in some cases, exit the nucleus bound to mRNAs,
directing their subsequent fate in the cytoplasm. Both
phosphorylation (Morton et al. 2006) and alternative splic-
ing (Fig. 2) may control the association of DAZAP1 with
complexes that are important for functions other than
translational activation.
Consistent with our finding that DAZAP1 stimulates trans-
lation in an mRNA-specific manner (Figs. 1, 4), there is
evidence that DAZAP1 is an mRNA-specific binding protein
in a variety of species. It was identified as an AU-rich binding
protein byRNA-affinity chromatography (Mortonet al. 2006),
shown to have a preference for AAAUAG and GU1-3AG
sequences by in vitro RNA selection (Hori et al. 2005), and
isolated in association with the 39 UTR of specific localized
mRNAs (Zhao et al. 2001) or RNAs containing specific splice
sites (Goina et al. 2008; Skoko et al. 2008).Our findings suggest
thatmRNAs that are translationally activated byDAZAP1may
contain multiple DAZAP1-binding sites within their 39 UTRs
(Fig. 6; Supplemental Fig. S1); however, verification of this will
require the identification of endogenous DAZAP1 target
mRNAs. Since DAZAP1 appears to be multifunctional, the
identification of mRNAs whose translational activation by
DAZAP1 underlies its contribution to development is com-
plicated by the likelihood that only a subset of DAZAP1-
bound mRNAs will be translationally controlled by
DAZAP1. Therefore, translational profiling in knockout
or knockdown animals will be required to identify these
mRNAs. This will first require a more detailed description
of the developmental defects associated with loss of
function to identify which developmental stages and cell
types may contain mRNAs that are translationally mis-
regulated in the absence of DAZAP1.
In summary, this study identifies DAZAP1 as a novel reg-
ulator of mRNA-specific translation that acts downstream
from the initial cap-binding event and raises interesting
questions pertaining to itsmechanism of action. Thus, future
work will be directed at identifying direct or indirect in-
teractions of DAZAP1 with translation factors bound to the
59 or 39 ends of the mRNA.
MATERIALS AND METHODS
Plasmids
Plasmids expressing MS2-fusion proteins pMS2-U1A, pMS2-
PABP (Gray et al. 2000), pMS2-Dazl (Collier et al. 2005), and
pMSPN (MS2) (Wilkie et al. 2005) have been previously de-
scribed. Plasmids expressing reporter mRNAs pLG-MS2 (luc-
MS2, also known as luc-MS23), pLGENB1 (luc-DMS2) (Gray et al.
2000), pMS2-1, pMS2-9, pLuc-MS2-pA (Collier et al. 2005),
pPV-Luc-MS2, pCSFV-Luc-MS2 (Gorgoni et al. 2005), pJK350
(b-galactosidase) (Evans et al. 1994), pHAV-Luc-MS2, and
pCSFV-lacZ (RWP Smith, O Larralde, B Gorgoni, P Malik, SV
Graham, and NK Gray, in prep.) have been described. pMS2-
hDAZAP (containing DAZAP1-201 [ENST00000233078]) and
the AA and DD derivatives were generated by Mark W. Peggie
and were a gift from Philip Cohen. pMS2-Prrp, containing
xDAZAP1 was created from pET-Prrp (a gift from Paul Huber)
by PCR using primers
59-GTCAGTGTCAGTGCTAGCATGAACAACCAAGGCGGGGAC-39
and
59-GTCAGTACTAGTTCAAATCCACTCGGACAATTTCAC-39
and inserted into pMSPN after digestion with NheI and SpeI.
pMSPN-DC (encoding an MS2 fusion of xDAZAP1 amino acids
1–192), pMSPN-D1 (MS2-xDAZAP1 amino acids 106–360), and
pMSPN-D1+2 (MS2-xDAZAP1 amino acids 193–360) were cre-
ated by PCR amplification of xDAZAP with primer pairs
59-GTCAGTGTCAGTGCTAGCATGAACAACCAAGGCGGGGA
C-39 and
59-CGCACTAGTTCATGGTTCTGCCCGTTTGACTTC-39,
59-GCGCGCTAGCCCCAGAACTGAAAACAGTAGGTC-39 and
59-GTCAGTACTAGTTCAAATCCACTCGGACAATTTCAC-39,
and
59-AGCTGCTAGCCGTGATAGCAAAAGCCAAACTCCAGG-39
and
59-GTCAGTACTAGTTCAAATCCACTCGGACAATTTCAC-39,
respectively, and insertion of the resulting products into the NheI
and SpeI sites in pMSPN. Plasmids used for yeast two-hybrid
analysis pBTM-4GNt, LexA-MS2, pACT-IRP (Gray et al. 2000),
pACT-eIF4E, and pBTM-eIF4G1 (expressing 4GDPABP) (Gorgoni
et al. 2005) were previously described. Plasmids for expression of
GAL4 activation domain fusions of hDAZAP1 (pACT-hDAZAP1)
and xDAZAP1 (pACT-xDAZAP1) were created by PCR amplifica-
tion of hDAZAP1 and xDAZAP1 with primer pairs
59-GTGTCAGTCCATGGAGATGAACAACTCGGGCGCCGAC-39
and
59-GTGTCAGTGGATCCCTAGCGTCGGTAGGGGTGGAACCC-39,
and
59-GTCAGTGTCAGTCCATGGAGATGAACAACCAAGGCGGGG
AC-39 and
59-GTGTCAGTAGATCTTCAAATCCACTCGGACAATTTCAC-39,
respectively, and insertion of the resulting products into the NcoI
and BamHI sites of pACT2 (Clontech). pET-hPABP1 was created
by PCR of hPABP1 with primer pair
59-GGATCCTTATGAACCCCAGTGCCCC-39 and
59-GTCGACTCAAACAGTTGGAACACCGGTGG-39
and insertion of the product into BamH1 and Sal1 sites of pET-
28c(+) (Novagen).
Isolation of X. laevis oocytes and generation
of embryos
Oocytes were manually dissected or released by collagenase
treatment—2.5 mg/mL collagenase in Marc’s modified ringer’s
Smith et al.
1292 RNA, Vol. 17, No. 7
solution (MMR; 100 mM NaCl, 2 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 5 mM HEPES at pH 7.4, and 1 mg/mL of penicillin and
streptomycin) for 1 h 30 min—from excised portions of ovary and
incubated at 18°C–22°C in MMR. Oocytes were matured by the
addition of 10 mg/mL progesterone (Sigma) and scored by the
appearance of a white spot on the animal pole. To obtain eggs for
fertilization, adult females were injected with 50 U of pregnant
mare serum (Calbiochem) 2–5 d prior to oviposition and induced
to lay eggs by injection with 600 U of human chorionic gonado-
tropin hormone (Sigma). Eggs were collected and smeared with
testes, macerated in 0.53 MMR. Fertilized eggs were identified
by contraction of the animal hemisphere and cortical rotation,
de-jellied in 2% cysteine (pH 8.0), and subsequently reared in
0.13 MMR. Embryos were staged according to the tables of
Nieuwkoop and Faber (1994) and collected by freezing on dry
ice.
Tethered-function analysis and metabolic labeling
Tethered-function assays were performed as described previously
(Gray et al. 2000). Briefly, in vitro transcribed mRNAs encoding
MS2-fusion proteins were microinjected into stage VI X. laevis
oocytes. Following incubation, reporter and control mRNAs were
co-injected, and oocytes were incubated overnight. Luciferase
reporter mRNAs were m7GpppG-capped except those contain-
ing an IRES or when specifically stated (ApppG). At least three
groups of five oocytes were harvested per point, and the levels of
luciferase and b-galactosidase activity were assayed in duplicate.
Data are derived from a minimum of three experimental repeats,
and error bars on the graphs represent SEM. Expression of MS2-
fusion proteins was confirmed by metabolic labeling with 100
mCi/mL [
35
S]-methionine for 6 h, as described (Gray et al. 2000).
In vitro protein expression
MS2-xDAZAP1 and MS2-hDAZAP1 were expressed from pMS2-
Prrp and pMS2-hDAZAP, respectively, using the TNT/T7 system
(Promega) supplemented with 10 mCi
35
S-methionine.
RNA stability analysis
Total RNA was extracted from injected oocytes (Gray et al. 2000),
and first-strand cDNA was synthesized from total RNA with an
AMV Reverse Transcriptase Kit (Roche) according to the manu-
facturer’s instructions. Quantitative RT-PCR analysis was per-
formed with an ABI 7500 Fast Real-Time PCR System (ABI) by
SYBR I green incorporation with luciferase primers
59-GGCGCGGTCGGTAAAGTT-39 and
59-AGCGTTTTCCCGGTATCCA-39.
Data analysis was performed with AB17500 software. All samples
were analyzed in duplicate, and the mean Ct values were plotted.
Error bars represent SEM.
Polysome analysis
Three milligrams of stage VI oocyte extract was subjected to
sucrose density-gradient analysis on a 10%–50% gradient and
fractionated as described (Gillian-Daniel et al. 1998). Thirty stage
40–41 embryos were lysed in basic lysis buffer (300 mM KCl, 10
mM MgCl2, 20 mM Tris-HCl at pH 7.4) supplemented with 0.5%
sodium deoxycholate and either 150 mg/mL cycloheximide, 250
mg/mL puromycin, or 25 mM EDTA. Lysates were fractionated
on a 10%–50% sucrose gradient over a 65% cushion in basic lysis
buffer and centrifuged for 2 h at 38,000 rpm in a TH461 ultra-
centrifuge rotor at 4°C. A254 profiles were analyzed on a density
gradient-fractionation system (Teledyne Isco), and proteins were
extracted from fractions by precipitation with 10% TCA prior to
Western blot analysis.
Antibody generation
Antibodies were raised in New Zealand White rabbits with
xDAZAP1-specific peptides
SGQQDFPFSQFGNAC and CGWTGQPPQTWQGYS,
conjugated to keyhole limpet hemocyanin. Bleeds were checked
for reactivity, and the anti-serum from bleed 3 was affinity
purified with antigenic peptides (CovalAb).
Protein extraction
Stage VI oocytes and embryos (stages 4–41) were lysed by
mechanical disruption in RIPA buffer (50 mM Tris-HCl at pH
7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1%
sodium deoxycholate, 2 mM DTT) supplemented with 2.5 mM
sodium b-glycerophosphate, 1 mM sodium orthovanadate, 25
mM NaF, 10 nM Calyculin A, 1 mM PMSF, 5 mg/mL Aprotinin, 5
mg/mL Leupeptin, 10 mM Pepstatin A, and 15 mM E64. Lysates
were cleared by centrifugation at 13,000g for 5 min at 4°C, and the
supernatants were retained. Protein concentrations were deter-
mined by Bradford assay, and equal amounts of protein were used
for Western blot analysis.
Calf intestinal phosphatase treatment
Stage VI or progesterone matured oocytes were lysed by mechan-
ical disruption in dephosphorylation buffer (25 mM HEPES at
pH 7.6, 300 mM NaCl, 1.5 mM MgCl2, 1% Triton-X-100, 0.1 mM
DTT, EDTA-free protease inhibitor tablets [Roche]). Equal
amounts of protein lysate, as determined by Bradford assay, were
incubated with calf intestinal phosphatase (CIP; 0.25 U/mg lysate)
for 2 h at 37°C before boiling for 10 min at 90°C in protein
loading buffer, followed by Western blot analysis.
Western blotting
Extracts or sucrose gradient fractions were resolved on either
10% SDS-PAGE gels or 4%–12% NuPAGE gels (Invitrogen) and
transferred to polyvinylidene fluoride membranes (Millipore).
Membranes were probed with anti-xDAZAP1 (1:1000), anti-ePABP
(1:3,000) (Wilkie et al. 2005), or anti-PABP1 (1:2000) (Wilkie et al.
2005), anti-tubulin (1:10,000; Sigma Aldrich), anti-phospho-ERK1/
2 (1:2,000; Cell Signaling Technology), anti-ERK1/2 (1:1,000; Cell
Signaling Technology), anti-polyhistidine (1:1,000; Sigma Aldrich),
or RED2 anti-PABP1 (1:3000) antibody (gift from Simon Morley).
Goat anti-rabbit IgG conjugated to horseradish peroxidase
(1:150,000) secondary antibodies were used (Sigma Aldrich) and
detected by enhanced chemiluminescence (Amersham/Thermo
Fisher).
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Expression and purification of recombinant proteins
Five hundred milliliter cultures of E. coli BL21(DE3), transformed
with pET-hPABP1 or pMS2-hDAZAP, were induced at an optical
density (600 nm) of 0.4, with 1 mM IPTG for 4 h at 22°C. Cells
were lysed in 5 mL of lysis buffer (13 BugBuster [Novagen], 50
mM Tris-HCl at pH 8, 100 mM NaCl, 1 kU/mL Lysozyme, 25
U/mL Benzonase, EDTA-free protease inhibitor tablets [Roche])
for 20 min at room temperature. Clarified lysate was incubated
with 500 mL Ni-NTA agarose (Qiagen) for 3 h at 4°C, washed six
times with 10 mL wash buffer (50 mM Tris-HCl at pH 8, 300 mM
NaCl, 20 mM imidazole, 0.2% NP40, EDTA-free protease in-
hibitor tablets [Roche]), and incubated in 500 mL elution buffer
(50 mM Tris-HCl at pH 8, 100 mM NaCl, 0.05% NP40, 300 mM
imidazole, 30% glycerol, EDTA-free protease inhibitor tablets
[Roche]) for 10 min at 4°C with gentle agitation. The eluate was
collected and stored at 80°C. Proteins were resolved on 4%–12%
NuPAGE gels (Invitrogen) and either stained with GelCode Blue
(Pierce) or quantified using SyproRuby (Invitrogen) alongside
BSA standards, followed by scanning with a Typhoon Variable
Mode Imager and quantification using ImageQuant software (GE
Healthcare).
Protein–protein interactions
Yeast two-hybrid analysis was performed using the strain L40 as
described (Gray et al. 2000). For Flag–pull-down assays, 30 pmol
of purified recombinant hPABP1 or hDAZAP1 was incubated
with 3 pmol of purified Flag-tagged human eIF4G and 30 mL anti-
Flag M2 Affinity Gel (Sigma-Aldrich), in binding buffer (50 mM
Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM DTT, 0.5% NP40,
EDTA-free protease inhibitor tablets [Roche]) for 3 h at 4°C with
agitation, washed six times in 1 mL binding buffer, and boiled for
10 min in 30 mL protein loading buffer. Samples were subjected to
Western blot analysis using an anti-polyhistidine antibody (Sigma-
Aldrich).
Bioinformatic analysis
Alternate forms of hDAZAP1 were identified in EnSEMBL and the
alternative C-terminal exon of DAZAP1-202 (ENSP00000337132)
was used to blastp search nonredundant protein sequences (nr),
retrieving a sequence from X. laevis AAH77252.1. The human and
X. laevis splice variants were aligned using color align conserva-
tion in the sequence manipulation suite (Stothard 2000).
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